| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $146K | — | +190.3% |
| Cost of Revenue | $194K | — | +797.5% |
| Gross Profit | -$48K | — | -266.7% |
| R&D Expense | $5.9M | — | +21.8% |
| SG&A Expense | $2.5M | — | -9.7% |
| Operating Income | -$9.2M | — | -7.7% |
| Pre-tax Income | -$9.1M | — | -21.5% |
| Income Tax | $520 | — | -95.7% |
| Net Income | -$9.1M | — | -21.3% |
| EPS (Basic) | -$4.06 | — | -1591.7% |
| EPS (Diluted) | -$4.06 | — | -1591.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.2M | -30.7% | +332.5% |
| Accounts Receivable | $82K | -56.7% | -39.6% |
| Inventory | $846K | -14.7% | -21.9% |
| Current Assets | $9.8M | -28.6% | -59.0% |
| Total Assets | $21.5M | -13.1% | -61.0% |
| Current Liabilities | $4.3M | +21.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.8M | — | +10.3% |
| Capital Expenditures | $142K | — | +54.5% |
| Investing Cash Flow | -$142K | — | -101.9% |
| Financing Cash Flow | $4.3M | — | +1121.9% |
| Free Cash Flow | -$8.0M | — | +9.6% |
| -20.3% |
| Total Liabilities | $5.5M | +32.7% | -24.5% |
| Stockholders' Equity | $16.0M | -22.2% | -66.5% |